On Thursday shares of Mylan N.V. (NASDAQ:MYL) closed at $72.26. Company’s sales growth for last 5 years was 8.70% and EPS growth for next 5 years is recorded as 13.36%. Mylan NV (NASDAQ:MYL) Chairman Robert Coury’s compensation rose 46 percent to $22.5 million in 2014, the drugmaker said Thursday, as it fights off a takeover approach from rival Teva Pharmaceutical Industries Ltd. Mylan’s board unanimously rejected a $40.1 billion takeover offer from Teva on Monday, saying the offer was too low and didn’t address the challenges of combining two companies with different cultures.
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) in last trading activity fell -5.42% to close at $20.06. Company weekly performance is -17.99% while its quarterly performance stands at -23.44%. Five Prime Therapeutics, Inc. (NASDAQ:FPRX) is -29.54% away from its 52 week high. Five Prime Therapeutics, Inc. (NASDAQ:FPRX) announced that the company will hold its first Research & Development Day event for the institutional investment community in New York City on May 5, 2015.
On last trading day Integra LifeSciences Holdings Corporation (NASDAQ:IART) fell -3.47% to close at $58.78. Its volatility for the week is 3.16% while volatility for the month is 2.20%. IART’s sales growth for past 5 years was 6.30% and its EPS growth for past 5 years was -10.00%. Integra LifeSciences Holdings Corporation (NASDAQ:IART) monthly performance is -4.66%. Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced the appointment, effective May 1, 2015, of Keith Valentine as Chief Executive Officer of SeaSpine Holdings Corporation, which will be an independent, publicly traded company following the completion of its spin-off from Integra. SeaSpine, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, located in Vista, CA, has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions.
OmegaFlex, Inc. (NASDAQ:OFLX) has 76.84% insider ownership while its institutional ownership stands at 20.20%. In last trading activity company’s stock closed at $29.79. On April 22, Omega Flex, Inc (NASDAQ:OFLX) has reported a 43.19 percent jump in profit for the quarter ended Mar. 31, 2015. The company has earned $3.14 million, or $0.31 a share in the quarter, compared with $2.20 million, or $0.22 a share for the same period last year.
On last trading day Albany Molecular Research Inc. (NASDAQ:AMRI) fell -0.88% to close at $18.06. Its volatility for the week is 3.94% while volatility for the month is 3.55%. AMRI’s sales growth for past 5 years was 7.10% and its EPS growth for past 5 years was 28.60%. Albany Molecular Research Inc. (NASDAQ:AMRI) monthly performance is 2.61%. Albany Molecular Research Inc (NASDAQ:AMRI) announced it will issue first quarter 2015 financial results before the opening of the market onTuesday, May 5, 2015.